Stock FAQs

quest diagnostics stock price history

by Alize Olson Published 3 years ago Updated 2 years ago
image

Where can I find the latest dividend history for Quest Diagnostics (DGX)?

Find the latest dividend history for Quest Diagnostics Incorporated Common Stock (DGX) at Nasdaq.com. Quest Diagnostics Incorporated Common Stock (DGX) Dividend History | Nasdaq Skip to main content

Who holds Quest Diagnostics'stock?

Only 1.45% of the stock of Quest Diagnostics is held by insiders. 91.51% of the stock of Quest Diagnostics is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Earnings for Quest Diagnostics are expected to decrease by -41.49% in the coming year, from $13.86 to $8.11 per share.

Is Quest Diagnostics'downside down 4% from current price?

According to analysts' consensus price target of $160.70, Quest Diagnostics has a forecasted downside of 4.7% from its current price of $168.61. Quest Diagnostics has only been the subject of 3 research reports in the past 90 days. Quest Diagnostics has received 497 “outperform” votes. (Add your “outperform” vote.)

How much money does Quest Diagnostics make a year?

Quest Diagnostics has a market capitalization of $20.66 billion and generates $9.44 billion in revenue each year. The medical research company earns $1.43 billion in net income (profit) each year or $16.65 on an earnings per share basis. How many employees does Quest Diagnostics have? Quest Diagnostics employs 49,000 workers across the globe.

See more

image

Is Quest Diagnostics stock a good buy?

We believe that Quest will benefit over the next year from its new coronavirus tests, increased demand for testing services, and strong cost controls. As such, our rating remains BUY with a target price of $135.

Is Quest Labs publicly traded?

Stock Quote (U.S.: NYSE) | MarketWatch....$ 136.34.CloseChgChg %$135.74-0.02-0.01%

Who bought Quest Diagnostics?

In May 2018, the company announced it will become an in-network laboratory provider to UnitedHealthcare starting in 2019, providing access to 48 million plan members.

How much market share does Quest Diagnostics have?

DGX's vs. Market share relative to its competitors, as of Q1 2022COMPANY NAMETICKERMARKET SHARE MRQ Q1 2022Quest Diagnostics IncDGX40.10 %Laboratory Corporation Of America HoldingsLH59.90%SUBTOTAL100%Apr 30, 2022

Which one is better labcorp or Quest Diagnostics?

Labcorp is most highly rated for Compensation and benefits and Quest Diagnostics is most highly rated for Compensation and benefits.

Is Quest owned by labcorp?

LabCorp and Quest Diagnostics are publicly-traded companies but they have different subsidiaries, which specialize in various protocols.

Who is bigger Quest or LabCorp?

For years, Quest was the largest, but LabCorp took over that spot a few years ago. Both companies are noted for growth through acquisition, and 2017 has been a very big year for LabCorp. Since 2008, LabCorp has acquired 19 companies.

Who are Quest Diagnostics competitors?

Quest Diagnostics's top competitors include Invitae, Sonic Healthcare, Abbott, Thermo Fisher Scientific and Labcorp. Quest Diagnostics is a company providing diagnostic testing, information, and other services.

Did LabCorp and Quest Diagnostics merge?

On Friday, May 25th UnitedHealth and Aetna announced that beginning on January 1, 2019 both LabCorp and Quest will become in-network labs for both of the insurers. LabCorp will continue its role as United's exclusive national laboratory provider through the end of 2018 and Quest will do the same for Aetna.

How many employees does Quest have?

Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 50,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.

How many labs does Quest have?

With QuestDirect, conveniently shop online and choose from over 45+ lab tests. No doctor's visit required.

What is Quest Diagnostics known for?

Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management.

Should I buy or sell Quest Diagnostics stock right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Quest Diagnostics in the last twelve months. There are currently 7 hold r...

What is Quest Diagnostics' stock price forecast for 2022?

10 brokerages have issued 12 month target prices for Quest Diagnostics' stock. Their forecasts range from $129.00 to $170.00. On average, they expe...

How has Quest Diagnostics' stock performed in 2022?

Quest Diagnostics' stock was trading at $173.01 on January 1st, 2022. Since then, DGX stock has decreased by 24.1% and is now trading at $131.25....

When is Quest Diagnostics' next earnings date?

Quest Diagnostics is scheduled to release its next quarterly earnings announcement on Thursday, July 21st 2022. View our earnings forecast for Que...

How can I listen to Quest Diagnostics' earnings call?

Quest Diagnostics will be holding an earnings conference call on Thursday, July 21st at 8:30 AM Eastern. Interested parties can register for or lis...

How were Quest Diagnostics' earnings last quarter?

Quest Diagnostics Incorporated (NYSE:DGX) released its quarterly earnings results on Thursday, April, 21st. The medical research company reported $...

How often does Quest Diagnostics pay dividends? What is the dividend yield for Quest Diagnostics?

Quest Diagnostics announced a quarterly dividend on Tuesday, May 17th. Investors of record on Wednesday, July 6th will be paid a dividend of $0.66...

Is Quest Diagnostics a good dividend stock?

Quest Diagnostics(NYSE:DGX) pays an annual dividend of $2.64 per share and currently has a dividend yield of 1.96%. Quest Diagnostics has been incr...

How will Quest Diagnostics' stock buyback program work?

Quest Diagnostics announced that its Board of Directors has authorized a share repurchase program on Thursday, February 4th 2021, which allows the...

A Message From Steve Rusckowski

Green Bronx Machine and Quest Diagnostics Foundation Team up to Expand Acclaimed Indoor Gardening Curriculum to Inspire Healthier Students

At Quest Diagnostics, our vision is “Empowering better health with diagnostic insights.” Our goal is to make this a healthier world – not just for some, but for all. As we near the two-year anniver...

Bengals and a Good Cause Are Supported by Quest Colleagues in Cincinnati

Foundation grant will help NYC-based nonprofit expand reach to 15,000 underserved students in three states

Is It Too Late To Consider Buying Quest Diagnostics Incorporated (NYSE:DGX)?

Quest Diagnostics employees at the Cincinnati lab were thrilled about their local team, the Cincinnati Bengals, playing in this year’s Super Bowl against the Los Angeles Rams and came together to c...

UPDATE 2-Qiagen forecasts profit above estimates as non-COVID businesses rebound

Today we're going to take a look at the well-established Quest Diagnostics Incorporated ( NYSE:DGX ). The company's...

FORTUNE Magazine Names Quest Diagnostics One of 2022 "World's Most Admired Companies" For Eighth Consecutive Year

Diagnostics company Qiagen on Tuesday projected 2022 profit above market estimates, signaling that a rebound in its non-COVID businesses would offset a drop in coronavirus testing demand. Share of the company rose nearly 6% in extended trading as it also surpassed analysts' estimates for fourth-quarter sales.

Valley Brook Capital Group, Inc. Buys Advanced Micro Devices Inc, Tesla Inc, DuPont de Nemours ..

SECAUCUS, N.J., February 3, 2022 /3BL Media/ - Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has been selected as one of FO...

What is quest diagnostics?

Investment company Valley Brook Capital Group, Inc.

What is the dividend payout ratio of quest diagnostics?

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

When will quest diagnostics repurchase?

Quest Diagnostics does not yet have a strong track record of dividend growth. The dividend payout ratio of Quest Diagnostics is 22.18%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Quest Diagnostics will have a dividend payout ratio of 31.04% next year.

image
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 1 2 3 4 5 6 7 8 9